| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Gyre Pharmaceuticals | $25.23M | $25.49M | $27.87M | $22.06M | $26.77M | $30.56M | $37.2M | $22.52M |
| Gyre | — | — | — | — | — | — | — | $0 |
| All Other Segments | — | — | — | — | — | — | — | $0 |
| Total | $25.23M | $25.49M | $27.87M | $22.06M | $26.77M | $30.56M | $37.2M | $22.52M |